Identification of Potential Therapeutic Targets in the Liver of Pioglitazone-Treated Type 2 Diabetes Sprague-Dawley Rats via Expression Profile Chip and iTRAQ Assay

Table 1

KEGG pathway enrichment via gene expression profile chip (DM versus Pio).

Number	Pathway ID	Pathway	value
1	ko03008	Ribosome biogenesis in eukaryotes	2.92E − 02
2	ko04977	Vitamin digestion and absorption	4.21E − 02
3	ko04141	Protein processing in endoplasmic reticulum	1.21E − 01
4	ko00051	Fructose and mannose metabolism	1.48E − 01
5	ko00790	Folate biosynthesis	1.62E − 01
6	ko00071	Fatty acid metabolism	1.69E − 01
7	ko00970	Aminoacyl-tRNA biosynthesis	1.69E − 01
8	ko04960	Aldosterone-regulated sodium reabsorption	1.69E − 01
9	ko03040	Spliceosome	1.71E − 01
10	ko04612	Antigen processing and presentation	1.85E − 01